Renalytix Plc Share Price
Stocks
RENX
GB00BYWL4Y04
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
London S.E.
10:05:01 02/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 5.450 GBX | 0.00% |
|
-8.40% | -7.63% |
| 29/10 | Renalytix Plc Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 28/10 | Earnings Flash (RENX.L) Renalytix plc Reports FY26 Revenue $3.0M | MT |
| Market Cap | 1.33Cr 1.19Cr 1.09Cr 99.39L 1.86Cr 126.25Cr 1.9Cr 13Cr 5.26Cr 67Cr 5.01Cr 4.9Cr 210.48Cr | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 1.79Cr 1.6Cr 1.47Cr 1.34Cr 2.51Cr 169.8Cr 2.56Cr 18Cr 7.07Cr 90Cr 6.73Cr 6.59Cr 283.08Cr | EV / Sales 2024 |
1,10,59,330x | EV / Sales 2025 | 1,24,99,418x |
| Free-Float |
81.69% | Yield 2024 * |
-
| Yield 2025 | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| RENX | Delayed | |
OTC Markets
| RENXF | Delayed | |
|
Deutsche Boerse AG
| 2O9 | Delayed | |
|
Börse Stuttgart
| 2O9 | Delayed | |
|
Boerse Muenchen
| 2O9 | Real-time |
Last Transcript: Renalytix Plc
| 1 week | -8.40% | ||
| 1 month | -9.17% | ||
| 3 months | +94.64% | ||
| 6 months | +202.78% | ||
| Current year | -7.63% |
| 1 week | 5.15 |  | 6.1 |
| 1 month | 5.1 | | 6.2 |
| Current year | 1.6 | | 6.57 |
| 1 year | 1.6 | | 8.4 |
| 3 years | 1.6 | | 74.9 |
| 5 years | 1.6 | | 900 |
| 10 years | 1.6 | | 1,220 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 15/03/2018 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 28/05/2024 |
Howard Doran
PSD | President | 65 | 30/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James McCullough
BRD | Director/Board Member | 58 | 15/03/2018 |
| Chairman | 74 | - | |
Fergus Fleming
BRD | Director/Board Member | 59 | 15/03/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 13/02/26 | Buy | Founder | 250 | 0.0001% | ||
| 13/02/26 | Buy | Chief Financial Officer | 500 | 0.0001% | ||
| 13/02/26 | Buy | Founder | 500 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -8.40% | -26.15% | -87.18% | 4.41Cr | |
| -1.72% | +0.02% | +21.27% | +53.06% | 26TCr | |
| -1.16% | -1.58% | +7.11% | +18.82% | 16TCr | |
| +3.04% | -1.75% | -18.46% | +59.68% | 15TCr | |
| +4.84% | -3.32% | -55.30% | -16.10% | 6.08TCr | |
| +1.19% | +2.62% | -11.10% | -8.42% | 5.33TCr | |
| +2.56% | +4.63% | +14.06% | +44.59% | 5.3TCr | |
| +0.05% | -1.44% | +7.13% | +65.13% | 5.07TCr | |
| -1.05% | -1.62% | +19.64% | +65.70% | 4.93TCr | |
| -2.11% | -0.48% | +31.31% | +84.91% | 4.55TCr | |
| Average | +0.60% | -1.19% | -1.05% | +28.02% | 8.84TCr | |
| Weighted average by Cap. | +0.21% | +0.15% | +3.88% | +41.90% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 2.04 1.88 1.71 3.2 216.7 3.26 22.4 9.03 114.38 8.59 8.41 361.27 | 3 2.68 2.46 2.24 4.19 284.01 4.28 29.36 11.83 149.91 11.26 11.02 473.48 |
| Net income | -3.35Cr -2.99Cr -2.74Cr -2.49Cr -4.67Cr -316.73Cr -4.77Cr -33Cr -13Cr -167.17Cr -13Cr -12Cr -528.03Cr | -2.04Cr -1.82Cr -1.67Cr -1.52Cr -2.85Cr -193.13Cr -2.91Cr -20Cr -8.05Cr -101.94Cr -7.66Cr -7.49Cr -321.97Cr |
| Net Debt | 38.55L 34.42L 31.58L 28.73L 53.86L 36Cr 54.94L 3.77Cr 1.52Cr 19Cr 1.45Cr 1.42Cr 61Cr | 46L 41.07L 37.69L 34.28L 64.27L 44Cr 65.55L 4.5Cr 1.81Cr 23Cr 1.73Cr 1.69Cr 73Cr |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | GBX 5.450 | 0.00% | 4,48,082 |
| 30/26/30 | GBX 5.450 | 0.00% | 11,45,502 |
| 29/26/29 | GBX 5.450 | -2.68% | 5,95,554 |
| 28/26/28 | GBX 5.600 | -5.88% | 29,85,462 |
| 27/26/27 | GBX 5.950 | 0.00% | 6,16,207 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
Select your edition
All financial news and data tailored to specific country editions
